Alison T. Stopeck

Recent Advances in the Treatment of Malignant Melanoma with Gene Therapy

A. Stopeck, E. Hersh, Alison T. Stopeck, 1997, Molecular medicine.

Phase II study of SU5416—a small‐molecule, vascular endothelial growth factor tyrosine‐kinase receptor inhibitor—in patients with refractory myeloproliferative diseases

H. Kantarjian, G. Garcia-Manero, A. Stopeck, 2003, Cancer.